The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
APOE genotype and cognitive decline in a middle-aged cohort.
C K Blair; A R Folsom; D S Knopman; M S Bray; T H Mosley; E Boerwinkle; (Profiled Author: Knopman, David S)
Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis 55454, USA.
BACKGROUND: Most longitudinal studies of nondemented persons have reported greater cognitive decline among APOE epsilon4 carriers vs noncarriers. However, most studies involved elderly samples (aged 65+) and were not large enough to examine the three APOE alleles separately. METHODS: Change in cognitive function was examined over a 6-year period using three neuropsychological tests among four APOE genotype groups (epsilon2/2 + epsilon2/3, epsilon3/3 (referent), epsilon4/2 + epsilon4/3, epsilon4/4). The population-based sample included 1,693 African Americans and 6,202 Caucasians initially ages 47 to 68. RESULTS: There was increasingly greater cognitive decline from the epsilon2 group to the epsilon4/4 group in Caucasians for two of the three tests. The combination of APOE epsilon4 with hypercholesterolemia or diabetes showed the greatest cognitive decline. Among African Americans, only the test measuring psychomotor speed showed associations with APOE genotype. CONCLUSIONS: APOE epsilon4 is associated with greater cognitive decline in middle-aged Caucasian individuals, with a reduced decline among epsilon2 carriers. This suggests that the processes by which APOE genotype mediates dementia risk are operative well in advance of overt dementia.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
1 February 1989 - 30 June 2009
NATIONAL INSTITUTE ON AGING
Total Funding: $ 40,531,208
HYMAN, BRADLEY T
30 September 2009 - 31 August 2011
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,039,362
COLE, GREGORY M
1 September 2011 - 31 March 2016
NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE
Total Funding: $ 1,109,185
R S Wilson; J L Bienias; E Berry-Kravis; D A Evans; D A BennettJournal of neurology, neurosurgery, and psychiatry 2002;73(6):672-7.
David A Bennett; Philip L De Jager; Sue E Leurgans; Julie A SchneiderNeurology 2009;72(17):1495-503.
R Stewart; C Russ; M Richards; C Brayne; S Lovestone; A MannDementia and geriatric cognitive disorders 2001;12(4):251-6.
Appears in this Publication
Author of this Publication